HowardJEisenMD

PubMed

• Going the distance: Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidan...
  Maria T Gamero, Yevgeniy Brailovsky, Howard J Eisen
  The Journal of Heart and Lung Transplantation. 2024-12-01
• Heart Transplantation Outcomes in Patients With Hypertrophic Cardiomyopathy in the Era of Mechanical Circulatory Support.
  Matylda Mazur, Robert Dowling, Geetha Bhat, Andres Carmona Rubio, Howard J Eisen
  ASAIO Journal. 2024-11-11
• Impact of the New Heart Allocation System on the Medium-Term Outcomes in Patients With Hypertrophic Cardiomyopathy.
  Matylda Mazur, Andres Carmona Rubio, Howard J Eisen, Geetha Bhat, Robert Dowling
  ASAIO Journal. 2024-09-01

Journal Articles

• Novel, More Accurate Assessments of Renal Function in Heart Transplant Patients: Commentary on 'Chronic kidney disease after heart transplantation: a single-centre r...  
  Kim DH, Eisen HJ, Transpl Int, 1/1/2016
• Pediatric Heart Transplant Recipients and Cardiac Allograft Vasculopathy: The Importance of Hemodynamics  
  Eisen HJ, J Am Coll Cardiol, 1/4/2015
• Improvements in Dutch heart transplant patient outcomes: lessons for the future  
  Eisen HJ, Transpl Int, 1/1/2015
• Preface Heart failure  
  Eisen HJ, Cardiol Clin, 1/1/2014
• Glutathione s-transferase Pi-1: a novel approach to mitigating adverse cardiac remodeling after myocardial infarction  
  Eisen HJ, J Card Fail, 1/1/2014
• Trends in the Prevalence of Hospitalization Attributable to Hypertensive Diseases Among United States Adults Aged 35 and Older from 1980 to 2007  
  Liu L, An Y, Chen M, Liu Z, Hu X, Chou E, Eisen HJ, Am J Cardiol, 1/28/2013
• Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial  
  Eisen HJ, Kobashigawa J, Starling RC, Pauly DF, Kfoury A, Ross H, Wang SS, Cantin B, Van Bakel A, Ewald G, Hirt S, Lehmkuhl H, Keogh A, Rinaldi M, Potena L, Zuckermann..., Am J Transplant, 1/1/2013
• The MELD scoring system and the prediction of outcomes in heart failure patients: what we have learned from the hepatologists  
  Eisen HJ, J Am Coll Cardiol, 1/1/2013
• Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency  
  Zuckermann A, Keogh A, Crespo-Leiro MG, Mancini D, Vilchez FG, Almenar L, Brozena S, Eisen H, Tai SS, Kushwaha S, Am J Transplant, 1/1/2012
• A novel definition of cardiac allograft vasculopathy  
  Eisen HJ, Am J Transplant, 1/1/2012
• International Society of Heart and Lung Transplantation Guidelines  
  The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients.Costanzo MR, Dipchand A, Starling R, Anderson A, Cha..., J Heart Lung Transplant, 1/1/2010
• Clinical Implications and Longitudinal Alteration of Peripheral Blood Transcriptional Signals Indicative of Future Cardiac Allograft Rejection  
  Mehra M, Deng MC, Eisen HJ, J Heart Lung Transplant, 1/1/2008
• Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysis  
  Vigano M, Tuzcu M, Benza R, Boissonnat P, Haverich A, Hill J, Laufer G, Love R, Parameshwar J, Pulpon LA, Renlund D, Abeywickrama K, Cretin N, Starling RC, Eisen HJ; R..., J Heart Lung Transplant, 1/1/2007
• Micronutrients, inflammation and congestive heart failure among the elderly: nutritional perspectives on primary prevention and clinical treatment  
  Liu L, Yin X, Ikeda K, Sullivan, Eisen HJ, Clin Exp Pharm Physiol, 1/1/2007
• Transcriptional Signals of T Cell and Corticosteroid Sensitive Genes are Associated with Future Acute Cellular Rejection in Cardiac Allografts  
  Mehra M, Kobashigawa J, Deng MC, Fang KC, Klingler TM, Lal PG, Rosenberg S, Uber PA, Starling RC, Murali S, Pauly DF, Dedrick R, Walker MG, Zeevi A, Eisen HJ, J Heart Lung Transplant, 1/1/2007
• Long-term cardiovascular risk in transplantation--insights from the use of everolimus in heart transplantation  
  Eisen HJ, Nephrol Dial Transplant, 1/1/2006
• Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients:...  
  Kobashigawa JA, Renlund DG, Gerosa G, Almenar L, Eisen HJ, Keogh AM, Lehmkuhl HB, Livi U, Ross H, Segovia J, Yonan N; ERL2401 Heart Study Investigators, J Heart Lung Transplant, 1/1/2006
• Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression Profiling  
  Deng MC, Eisen HJ, Mehra MR, Billingham M, Marboe CC, Kobashigawa J, Johnson FL, Starling RC, Murali S, Pauly DF, Baron H, Wohlgemuth JG, Woodward RN, Klingler TM, Wal..., Am J Transplant, 1/1/2006
• Molecular testing in the management of cardiac transplant recipients: initial clinical experience  
  Starling RC, Pham M, Valantine H, Miller L, Eisen H, Rodriguez ER, Taylor DO, Yamani MH, Kobashigawa J, McCurry K, Marboe C, Mehra MR, Zuckerman A, Deng MC, Working Gr..., J Heart Lung Transplant, 1/1/2006
• Statin Use and Risk of Death or Fatal Rejection in the Heart Transplant Registry  
  Wu AH, Ballantyne CM, Short BC, Torre-Amione G, Young JB, Ventura HO, Eisen HJ et al, Am J Cardiol, 1/1/2005
• Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients  
  Marboe CC, Billingham M, Eisen H, Deng MC, Baron H, Mehra M, Hunt S, Wohlgemuth J, Mahmood I, Prentice J, Berry G, J Heart Lung Transplant, 1/1/2005
• Post-operative obesity and cachexia are risk factors for morbidity and mortality after heart transplant: multi-institutional study of post-operative weight change  
  Grady KL, Naftel D, Pamboukian SV, Frazier OH, Hauptman P, Herre J, Eisen H, Smart F, Bourge R; Cardiac Transplant Research Database Group, J Heart Lung Transplant, 1/1/2005
• Mycophenolate Mofetil Cardiac Study Investigators Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in ca...  
  Eisen HJ, Kobashigawa J, Keogh A, Bourge R, Renlund D, Mentzer R, Alderman E, Valantine H, Dureau G, Mancini D, Mamelok R, Gordon R, Wang W, Mehra M, Constanzo MR, Hum..., J Heart Lung Transplant, 1/1/2005
• The economic implications of noninvasive molecular testing for cardiac allograft rejection  
  Evans RW, Williams GE, Baron HM, Deng MC, Eisen HJ, Hunt SA, Khan MM, Kobashigawa JA, Marton EN, Mehra MR, Mital SR, Am J Transplant, 1/1/2005
• Early Growth Responsive Gene-1 (Egr-1) Expression Correlates with Cardiac Allograft Rejection  
  Autieri MV, Kelemen SE, Gaughan JP, Eisen HJ, Transplantation, 1/15/2004
• Join now to see all

Books/Book Chapters

• Cardiac Arrhythmias: Mechanisms, Diagnosis and Management 
  Chapter: Arrhythmias in Cardiac Transplantation 
  Page 907 - 923Rothman S, Wald JW and Eisen HJEditors: Podrid PJ and Kowey PR.Lippincott Williams and Wilkins, Philadelphia, PAEdition 2nd,2001
• American Society of Transplantation Primer 
  Chapter: Left Ventricular Dysfunction After Cardiac Transplantation; Etiologies, Diagnosis and Treatment 
  Page 366 - 369Eisen HJEditors: Norman D and Turka L.Thorofare, New Jersey American Society of TransplantationEdition 2nd,2001
• Pocket Guide to Cardiovascular Diseases 
  Chapter: Heart transplantation 
  Page 594 - 614Eisen HJ and Pina IPEditors: Chung EK and Tighe DA.Blackwell Science, Inc, Malden, MAEdition 1st,1999
• Temple University School of Medicine Cardiovascular Pathophysiology Syllabus 
  Chapter: Valvular Heart Disease 
  Eisen HJ1994
• Perioperative Medicine 
  Chapter: The surgical patient with congestive heart failure 
  Page 197 - 203Eisen HJEditors: Goldmann DR, Brown FH, Guarnieri DM.McGraw-Hill, Inc, New York, NYEdition 2nd,1993
• University of Pennsylvania Internal Medicine Board Review Syllabus 
  Chapter: Shock 
  Eisen HJ1992
• University of Pennsylvania Internal Medicine Board Review Syllabus 
  Chapter: Pericardial Disease, Cardiomyopathy, Congestive Heart Failure and Systemic Diseases Involving the Heart 
  Eisen HJ1990
• Join now to see all

Abstracts/Posters

• Identification of cardiac allograft rejection using Raman spectrophotometry
  Rassadi S, Chang C, Cao D, Eisen HJ, J Heart Lung Transplant, 1/1/2007
• Novel immunosuppressive strategies using a molecular diagnostic assay for weaning of immunosuppressive agents
  Albright K, Rowe T, Hankins SR, Eisen HJ, J Heart Lung Transplant, 1/1/2007
• Gene expression profiling distinguishes moderate to severe from mild acute cellular rejection in cardiac allograft recipients
  Bernstein D, Berry G, Billingham M, Marboe CC, Deng MC, Mital S, Eisen H, Williams GE, Baron H, Klingler TM, Wohlgemuth JG, Kobashigawa J, J Heart Lung Transplant, 1/1/2007
• Does induction therapy influence the utility of gene expression testing for cardiac allograft rejection
  Mehra M, Deng MC, Starling R, Murali S, Pauly D, Lal P, Cadeiras M, Baron H, Rosenberg S. Eisen H, J Heart Lung Transplant, 1/1/2007
• Everolimus in de novo heart transplant recipients: six month data on cyclosporine reduction and impact on renal function
  Keogh A, Wang SS, Zuckermann A, Ross H, Frigerio M, Eisen H, Bara C, Laufer G, Cotrufo M, Lena S, Sips C, J Heart Lung Transplant, 1/1/2007
• 12 month report of a 3 arm multicenter comparison of tacrolimus (TAC), MMF or TAC-Sirolimus (SRL) and steroids vs. cyclosporine microemulsion (CYA), MMF and steroids i...
  Kobashigawa J, Miller LW, Felker GM, Russel SD, Ewald GA, Zucker M, Goldberg L, Eisen HJ, et. al., J Heart Lung Transplant, 1/1/2005
• Evaluation of cyclosporine (CsA) profiles month 2 to 6 in an international phase III randomized, multicenter, double-blind study of everolimus in de novo heart transpl...
  Eisen HJ, Mancini D, Vigano M, Kobashigawa J, J Heart Lung Transplant, 1/1/2005
• Expression and anti-proliferative effects of interleukin-19 (IL-19) in allografted hearts and cultured smooth muscle cells
  Kelemen SE, Eisen HJ, Goldman BI, Autieri M, J Heart Lung Transplant, 1/1/2005
• Longitudinal monitoring of cardiac allograft recipients using peripheral blood gene expression profiling: A retrospective observational analysis of molecular testing ...
  Eisen HJ, Den MC, Klingler TM, Williams GE, Wohlgemuth JG, Mehra MR, J Heart Lung Transplant, 1/1/2005
• Factors affecting survival post heart transplantation: Comparison of pre and post 1999 listing protocols
  Bove AA, Cross RC, Kashem AM, Furukawa S, McClurken JB, Berman GO, Eisen HJ, J Heart Lung Transplant, 1/1/2005
• Twelve months results of enteric-coated mycophenolate sodium (EC-MPS) in de novo heart transplant patients showed excellent efficacy and safety
  Kobashigawa JA, Relund DG, Gerosa G, Caforio A, Ross H, Lehmkuhl HB, Eisen HJ, Segovia J, Brambilla, J Heart Lung Transplant, 1/1/2005
• Preiss M Evaluation of cyclosporine (CsA) profiles month 2 to 6 in de novo heart transplant recipients
  Eisen HJ, Mancini D, Vigano M, Kobashigawa J, Am J Transplant, 1/1/2005
• Everolimus in Cardiac Transplantation: 48 Month Results
  Kobashigawa, J Hare J, Eisen H, McCurry K, Hauptman P, Simonsen S, Arizon J, Perrone S, Jarcho J, Moeller V, Am J Transplant, 1/1/2005
• 4-Year Incidence of MACE and Economic Burden in de novo heart transplant patients: a comparison of everolimus and azathioprine
  Eisen H, Starling R, Yang X L, Ricci J F, Kobashigawa J, Am J Transplant, 1/1/2005
• Incidence of new Onset Diabetes Mellitus (NODM) following orthotopic heart transplantation
  Eisen HJ, Irish WD, Schnitzler MA, Am J Transplant, 1/1/2005
• Wohlgemuth.Non-Invasive Molecular Screening for Acute Cardiac Rejection: A Multicenter Prospective Clinical Study
  Eisen HJ, M.C. Deng, M. Mehra, S. Hunt, F. Johnson, R. Robbins, M. Autieri, S. Itescu, J. Giacomini, D. Ahern, G. Berry, C. Marboe, I. Mahmood, R. Woodward, J, J Heart Lung Transplant, 1/1/2003
• Specific Dysregulation of Troponins and Inflammatory Marker Genes in Endomyocardial Biopsies from Heart Transplant Recipients
  S.E. Kelemen, D.P. Bednarik, M.V. Autieri, K.B. Margulies, H.J. Eisen, J Heart Lung Transplant, 1/1/2003
• Eisen.Transcriptional Profiling of the Vascular Smooth Muscle Cell Response to Allograft Injury
  M.V. Autieri, S.E. Kelemen, D.P. Bednarik, H.J, J Heart Lung Transplant, 1/1/2003
• Expression of Allograft Inflammatory Factor-1 in T-Lymphocytes: A Role in T-Cell Activation and Allograft Rejection
  S.E. Kelemen, H.J. Eisen, M.V Autieri, J Heart Lung Transplant, 1/1/2003
• Everolimus in De Novo Cardiac Transplant Recipients: 24-Month Follow-Up
  A. Haverich, E.M. Tuzcu, M. Vigano, L. Pulpon, R.B. Love, R. Dorent, H.J. Eisen, J. Murphy, K.H. Abeywickrama, P. Bernhardt, the RADB 253 Study Group, J Heart Lung Transplant, 1/1/2003
• Gaughan.Impact of BMI on Long-Term Survival after Heart Transplantation
  H.J. Eisen, S.A. Gowda, D. Beltramo, J. Manacchio, J.P, J Heart Lung Transplant, 1/1/2003
• Equivalent Survival Despite Higher Risk Profile in African American Heart Transplant Recipients
  D. Gupta, M. Macha, A.K. Singhal, J.B. McClurken, B.I. Goldman, J.P. Gaughan, H.J. Eisen, S. Furukawa, J Heart Lung Transplant, 1/1/2003
• Post-Operative Obesity and Cachexia Are Risk Factors for Post Heart Transplant Morbidity and Mortality: A Multi-Institutional Study of Post-Operative Weight Change
  K.L. Grady, D.C. Naftel, S. Pamboukian, O.H. Frazier, P. Hauptman, J. Herre, G. Torre, HJ Eisen, F. Smart, R.C. Bourge, J Heart Lung Transplant, 1/1/2003
• Diabetes and Cardiac Transplantation
  S Gowda, HJ Eisen, Am J Transplant, 1/1/2003
• Impact of Body Mass Index on Survival after Heart Transplantation
  S Gowda, D Beltramo, J Manacchio, HJ Eisen, Am J Transplant, 1/1/2003
• Join now to see all

Lectures

• Debate:Cardiac Biopsies are Essential for Post-Transplant Surveillance (Con and rebuttal) 
  Washington, DC - 1/27/2016
• Heart Failure Now and (Perhaps) in The Future 
  Feldkirch, Austria - 1/9/2016
• Biomarkers and Cardiac Transplantation 
  Santander, Spain - 1/7/2016
• Left Heart Failure as a Cause of Pulmonary Hypertension and Right Ventricular Failure 
  Washington, DC - 1/29/2015
• Therapy for Advanced Heart Failure: Now and (Perhaps) in the Future 
  Drexel University School of Medicine, Philadelphia, PA - 1/28/2015
• mTOR Inhibitors: Where's the Beef 
  Nice, France - 1/16/2015
• Evaluating the Age Advanced Heart Failure Patient for Cardiac Transplantation 
  San Francisco, CA - 1/28/2014
• Mechanical Circulatory Support and Advanced Heart Failure 
  Incheon, South Korea - 1/20/2014
• Every Cardiac Transplant Patient Should Receive mTOR Inhibitors (Pro) 
  San Diego, CA - 1/10/2014
• Pump Down: the Basic Science of Acute Cellular Ejection 
  San Diego, CA - 1/8/2014
• Treatment Options for the Sensitized Patient Awaiting Cardiac Transplantation 
  Seattle, WA - 1/21/2013
• The Effect of Psychosocial Factors in Clinical Outocmes in Patients With Mechanical Circulatory Support 
  Orlando, FL - 1/17/2013
• Proliferation Signal Inhibitors for the Prevention and Treatment of Cardiac Allograft Vasculopathy 
  Lake Louise, Alberta, Canada - 1/15/2013
• Management of Heart Failure 
  Sejong General Hospital, Seoul, South Korea - 1/11/2013
• Management of Advanced Heart Failure in the United States 
  Sejong General Hospital, Seoul, South Korea - 1/9/2013
• Infections After Cardiac Transplantation 
  Sejong General Hospital, Seoul, South Korea - 1/9/2013
• The Role of Proliferation Signal Inhibitors in Cardiac Transplantation 
  Boston, MA - 1/4/2013
• Mechanical Circulatory Support for Advanced Heart Failure 
  Morristown Memorial Hospital, Morristown, NJ - 1/28/2011
• Management of Advanced Heart Failure 
  Beth Israel-Deaconess Hospital, Boston, MA - 1/25/2011
• The History of the Drexel University College of Medicine 
  Sejong General Hospital, Seoul, South Korea - 1/19/2011
• Presentation of Results from Everolimus versus Mycopeholate mofetil Clinical Trial in Cardiac Transplantation 
  San Diego, CA - 1/14/2011
• Management of the Sensitized Cardiac Transplant Recipient 
  Reina Sophia Hospital/University of Cordoba, Cordoba, Spain - 1/12/2011
• Management of Cardiac Allograft Vasculopathy 
  Philadelphia, PA - 1/2/2011
• Genomics of Cardiac Transplantation 
  University of Florida, Gainesville, FL - 1/27/2010
• Gene Expression Profiling in Cardiac Transplantation 
  Chicago, IL - 1/22/2010
• Join now to see all

Other

• Acute cardiac allograft rejection:treatment 
  Jessup M, Eisen HJ, UpToDate in Medicine CD ROM
  1/1/2014
• Cardiac transplant vasculopathy: pathophysiology, diagnosis and treatment 
  Eisen HJ, UpToDate in Medicine CD ROM
  1/1/2014
• Cardiac transplantation: post-transplant lymphoproliferative disorders 
  Eisen HJ, UpToDate in Medicine CD ROM
  1/1/2014
• Hyperlipidemia in cardiac transplant recipients 
  Eisen HJ, UpToDate in Medicine CD ROM
  1/1/2014
• Cardiac arrhythmias following orthotopic heart transplantation 
  Kusmirek L, Eisen HJ, UpToDate in Medicine CD ROM
  1/1/2014
• Rehabilitation in cardiac transplantation 
  Pina IL, Eisen HJ, UpToDate in Medicine CD ROM
  1/1/2014
• Mechanical cardiac support 
  Jeevanandam V, Eisen HJ, UpToDate in Medicine CD ROM
  1/1/2014
• Arrhythmias following cardiac transplantation 
  Eisen HJ, Kusmirek LS
  http://www.uptodate.com/contents/arrhythmias-following-cardiac-transplantation
  UpToDate, Wolters Kluwer Health - 2012-04-11
• Acute cardiac allograft rejection: Diagnosis 
  Eisen HJ, Jessup M
  http://www.uptodate.com/contents/acute-cardiac-allograft-rejection-diagnosis
  UpToDate, Wolters Kluwer Health - 2012-02-29
• Acute cardiac allograft rejection: Treatment 
  Eisen HJ, Jessup M
  http://www.uptodate.com/contents/acute-cardiac-allograft-rejection-treatment
  UpToDate, Wolters Kluwer Health - 2012-04-12
• Lipid abnormalities after cardiac transplantation 
  Eisen HJ
  http://www.uptodate.com/contents/lipid-abnormalities-after-cardiac-transplantation
  UpToDate, Wolters Kluwer Health - 2012-09-28
• Pathogenesis of and risk factors for cardiac allograft vasculopathy 
  Eisen HJ
  http://www.uptodate.com/contents/pathogenesis-of-and-risk-factors-for-cardiac-allograft-vasculopathy
  UpToDate, Wolters Kluwer Health - 2012-10-25
• Prevention and treatment of cardiac allograft vasculopathy 
  Eisen HJ
  http://www.uptodate.com/contents/prevention-and-treatment-of-cardiac-allograft-vasculopathy
  UpToDate, Wolters Kluwer Health - 2012-02-27
• Join now to see all